CLENZIDERM PORE THERAPYACNE TREATMENT (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the CLENZIDERM PORE THERAPY drug offered from Valeant Pharmaceuticals North America LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | SALICYLIC ACID |
SUBSTANCE NAME: | SALICYLIC ACID |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2015-03-02 |
END MARKETING DATE: | 0000-00-00 |
CLENZIDERM PORE THERAPY ACNE TREATMENT HUMAN OTC DRUG Details:
Item Description | CLENZIDERM PORE THERAPY ACNE TREATMENT from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2015-03-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-6102_37d89871-9a5f-4927-9c7d-a450ab56ac70 |
PRODUCT NDC: | 0187-6102 |
APPLICATION NUMBER: | part333D |